GlassScriptPhysician profile
Seth Monroe Park
NPI 1730650144
$3,929.42
in general payments reported to CMS, 2019-2025
19 companies · $1,199 in 2025
The $1,199 reported for 2025 was more than what 86% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $108 · 2022: $459 · 2023: $1,052 · 2024: $1,112 · 2025: $1,199.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,157 · Education: $206.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,156.59 |
| Education | $206.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $924.46 | 2021-2025 | |
| Janssen Biotech, INC. | $494.06 | 2022-2025 | Tremfya |
| Lilly USA, LLC | $464.27 | 2023-2025 | Ebglyss, Olumiant, Taltz |
| Regeneron Healthcare Solutions, INC. | $444.04 | 2021-2025 | Dupixent |
| Genzyme Corporation | $372.93 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $299.26 | 2021-2025 | |
| Ucb, INC. | $237.43 | 2021-2025 | Bimzelx |
| Incyte Corporation | $116.92 | 2022-2023 | Opzelura |
| E.R. Squibb & Sons, L.L.C. | $112.93 | 2024-2025 | Sotyktu |
| Arcutis Biotherapeutics, INC. | $103.18 | 2023-2025 | Zoryve |
| Galderma Laboratories, L.P. | $66.46 | 2024-2025 | Nemluvio |
| Amgen INC. | $52.60 | 2023-2024 | Otezla, Enbrel |
| Organon LLC | $52.00 | 2025 | |
| Dermavant Sciences, INC. | $40.53 | 2023-2024 | Vtama |
| Leo Pharma INC. | $37.56 | 2022-2024 | Adbry |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $36.83 | 2023-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $33.62 | 2022-2023 | Spevigo |
| Sanofi-Aventis U.S. LLC | $29.00 | 2021 | |
| Kerecis Limited | $11.34 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Seth Monroe Park listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.